Deadline: 24-Feb-22
The Centers for Disease Control and Prevention (CDC) National Centers for Injury Prevention and Control (NCIPC) is soliciting investigator initiated research to improve the understanding of risk and protective factors, patterns, and trajectories related to polydrug use, with a focus on polydrug combinations most likely to result in nonfatal overdose or death, such as combinations including synthetic opioids.
Polydrug combinations of interest include the following:
- Co-use of multiple opioids, knowingly or unknowingly (ie, due to unknown adulterants)
- Co-use of non-opioid drugs (particularly psychostimulants [eg, methamphetamine], cocaine, and benzodiazepines) AND opioids, knowingly or unknowingly
- Co-use of other combinations of drugs that may result in drug overdose
Applicants shall focus on identifying risk and protective factors, AND patterns, AND trajectories of polydrug use for either 1) the general population OR 2) one or more of the following subpopulations of interest:
- Persons who have experienced acute or chronic pain and used prescription opioids to manage their pain
- Persons who use cannabis, either medically or non-medically
The overall goal of this research is to better understand risk and protective factors for and patterns and trajectories of polydrug use in order to inform focused drug use and overdose prevention efforts.
Objectives
Applicants are expected to focus on all three of the following primary research objectives:
- Identify risk and protective factors for polydrug use; AND
- Identify patterns of polydrug use. Patterns of drug use refers to descriptions of the drug use such as the combinations of drugs taken, the timing and sequence of such combinations (eg, concurrent vs. simultaneous use), the route of administration, and whether co-use is intentional or unintentional (ie, due to unknown adulterants); AND
- Identify trajectories of polydrug use and overdose. An individual’s drug use trajectory refers to an individual’s subsequent drug use over time after initiation of a drug or other precipitating factor.
Funding Information
- Estimated Total Funding: $ 5,250,000
- Award Ceiling: $ 350,000 Per Budget Period
- Total Period of Performance Length: 3 year (s)
- Anticipated Number of Awards: 5
Eligibility Criteria
- Eligibility Category:
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits without 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others
- Unrestricted
- Additional Eligibility Category:
- The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education:
- Hispanic-serving Institutions
- Historically Black Colleges and Universities (HBCUs)
- Tribally Controlled Colleges and Universities (TCCUs)
- Alaska Native and Native Hawaiian Serving Institutions
- Nonprofits (Other than Institutions of Higher Education):
- Nonprofits (Other than Institutions of Higher Education)
- Other:
- Faith-based or Community-based Organizations
- Regional Organizations
- The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education:
For more information, visit https://www.grants.gov/web/grants/view-opportunity.html?oppId=336247